Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,090 GBX | -0.67% | -1.95% | +14.08% |
10:01am | The FTSE 100 is taking a breather | |
08:47am | AstraZeneca's Antibody Cuts COVID-19 Risk Among Immunocompromised in Late-stage Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.96% | 239B | |
+35.01% | 709B | |
+30.54% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+9.23% | 211B | |
-3.35% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement